Tobacco Use Disorder, Tobacco Dependence, Tobacco Use Cessation
Conditions
Brief summary
The PROMPT Pilot Study is a feasibility mixed methods prospective cohort study following principles of community-based participatory action research. The study recruited 80 people who use drugs and followed them for 6 months while providing access to counselling, nicotine replacement therapy and peer-support in a community setting. A notable reduction in average cigarette use per day (20.5 to 9.3) and illicit substance use (18.8%) was observed at study-end. PROMPT's patient engagement model is an effective harm-reduction strategy for the growing opioid use crisis and can improve the health outcomes of marginalised at-risk populations worldwide.
Detailed description
Objective To determine the feasibility of a Community-Based Participatory Tobacco Dependence Strategy (PROMPT) in the inner city population of Ottawa (Canada). Design A feasibility mixed methods prospective cohort study following principles of community-based participatory action research. Intervention Recruited 80 people who use drugs, followed them for 6 months while providing access to counseling, nicotine replacement therapy and peer-support in a community setting. Setting Community research office in downtown Ottawa, adjacent to low-income housing, shelter services and street-based drug consumption. Primary outcome Retention rate at 6-month follow-up. Secondary outcome Biochemically validated 7-day point prevalence smoking abstinence at 26 weeks, self-reported abstinence in the past 7 days with exhaled carbon monoxide ≤10 ppm.
Interventions
One on one smoking cessation counselling with a certified mental health nurse
Access to a range of nicotine replacement therapy: nicotine patch, nicotine gum, nicotine lozenge, nicotine inhaler
Sponsors
Study design
Eligibility
Inclusion criteria
* currently living in Ottawa for at least 3 months prior to enrolment * 16 years or older * have used drugs in the past year (excluding marijuana and alcohol) * have smoked tobacco in the past 7 days
Exclusion criteria
* consent declined (refusal from participant or decision maker) * any person accessing addictions treatment (in-patient drug rehabilitation) and hence unavailable for follow-up * any person currently or recently (in the past 30 days) enrolled in a smoking cessation program * anyone with a terminal illness with a life expectancy of \<3 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Retention of Study Participants | 6 months | Retention rate at 6-month follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Biochemical Validation of Smoking Cessation Outcome | 6 months | Biochemically validated 7-day point prevalence smoking abstinence at 26 weeks, self-reported abstinence in the past 7 days with exhaled carbon monoxide ≤10 ppm. |